Marksans Pharma Limited — Others, 16-07-2025: Shareholders meeting

Marksans Pharma will hold its 33rd Annual General Meeting on August 8, 2025, via video conference. Shareholders will consider adopting financial results for FY25 and a proposed dividend of ₹0.80 per share. The agenda includes re-appointing Mrs. Sandra Saldanha and appointing Mr. Srinivas Mishra as an independent director, who brings banking and risk expertise. The company also seeks to appoint a Secretarial Auditor for ₹0.013 Cr for FY26. A key proposal is to amend the ESOP Scheme 2024 to include subsidiary employees. This enables granting up to 2.3 Cr options in total, with up to 1.15 Cr per employee, through fresh equity shares, enhancing group-wide talent retention.